Identifying simultaneous inhibition of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancer
Takako Ooshio, Yusuke Satoh, Hui Jiang, Tongwei Liu, Kiyonaga Fujii, Takamasa Ishikawa, Kaori Igarashi, Kaori Saitoh, Keiko Kato, Tetsuo Mashima, Shigeki Jin, Kotaro Matoba, Matthias Mack, Tsuyoshi Osawa, Hiroyuki Seimiya, , Masahiro Sonoshita
The paper identifies dual targeting of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancer by showing synergistic suppression of PDAC xenograft growth.
bioRxiv · Oct 23, 2024 · PreprintCancer Biology